Perindopril, A New Angiotensin Converting Enzyme Inhibitor—Clinical Pharmacological Studies in Healthy Subjects

John L. Reid Clinical Pharmacology Research Unit and Department of Materia Medica, University of Glasgow, Glasgow, Scotland

Kennedy R. Lees Clinical Pharmacology Research Unit and Department of Materia Medica, University of Glasgow, Glasgow, Scotland

Laurent Perret I.R.I.S., Neuilly sur Seine, France

References

Laubie M., Schiavi P., Vincent M., Schmitt H. Inhibition of angiotensin I-converting enzyme with S9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects. J. Cardiovas. Pharmacol. 1984; 6: 1076–1082
PubMed Web of Science ®Google Scholar
Lees K. R, Reid J. L. Effects in normotensive subjects of perindopril, an angiotensin converting enzyme inhibitor. Clinical Science 1985; 69: 49p
Web of Science ®Google Scholar
Lees K. R, Reid J. L. Single and multiple administration of an angiotensin converting enzyme inhibitor, S-9490–3, in normotensive subjects. Brit. J. Clin. Pharmacol. 1984; 19(1)132p–133p
Web of Science ®Google Scholar
Lees K. R, Kelman A. W, Meredith P., Reid J. L. Pharmacokinetics of the angiotensin converting enzyme inhibitor, perindopril, after repeated oral dosing. Brit. J. Clin. Pharmacol. 1986, (in press)
PubMed Web of Science ®Google Scholar
Chiknas S. G. A liquid chromatography-assisted assay for angiotensin converting enzyme (peptidyl dipeptidase) in serum. Clinical Chemistry 1979; 25(7)1259–1262
PubMed Web of Science ®Google Scholar
Sheiner L. B, Stanski D. R, Vozeh S., Miller R. D, Ham J. Simultaneous modelling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin. Pharmacol. Therap. 1979; 25(3)358–371
PubMed Web of Science ®Google Scholar
Kelman A. W, Reid J. L., Millar J. A. Concentration-effect modelling with converting enzyme inhibitors in man. Brit. J. Clin. Pharmacol. 1983; 15: 506–507
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Perindopril, A New Angiotensin Converting Enzyme Inhibitor—Clinical Pharmacological Studies in Healthy Subjects

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Perindopril, A New Angiotensin Converting Enzyme Inhibitor—Clinical Pharmacological Studies in Healthy Subjects

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date